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and, if needed, a new plan was re-optimized adaptively.  Set 
up was verified with gated orthogonal X rays and non-gated 
cone beam CT in treatment room. Threshold for gate-on 
signal was initially set at 10% pressure signal dynamic and 
qualitatively adjusted in an asymmetric way according to 
results of plan recalculation in 30% expiration and 
inspiration. Gating signal was fed to the accelerator to 
enable beam delivery. Each slice was re-scanned 5 times to 
smear out possible interplay effects.  Acute and early toxicity 
was scored according to CTCAE 4.0 scale. 
Results: GTV and diaphragm excursion between end 
expiration and adjacent 30% phases was reduced to less than 
5 mm. GTV (D95%) and critical OAR (D1%)  DVH in 30% 
inspiration and expiration phases showed on average minimal 
(less than 3%) differences as compared to planning end 
expiration plan. Toxicity was minimal with no G3 event; 15% 
acute G2 and 10% G2 toxicity at 3 months was observed. 
Median follow up was rather short (3 months) nevertheless in 
23 patients the dose limiting OAR was either stomach or 
small bowel or esophagus, therefore early toxicity data are 
informative. 
Conclusion: Active scanning with carbon ion beams for the 
treatment of moving target using abdominal compression, 4D 
simulation, robust planning gating and rescanning is feasible 
and safe. Longer follow up is needed to evaluate oncological 
outcome 
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In carbon ion radiotherapy (CIRT), mainly two calculation 
models are adopted to define relative biological 
effectiveness (RBE)-weighted doses (DRBE): the Japanese 
Kanai model and the Local Effect Model (LEM). Taken the 
Japanese longest-term clinical data as a reference, the use 
of a different RBE model, with no correction for the Gy (RBE) 
scale, leads to deviations in target absorbed dose (Dabs) with 
a potentially significant impact on tumor control probability. 
In this study we validate a conversion method linking the two 
DRBE systems, confirming DRBE prescription dose values 
adopted in our LEM-based protocols.  
The NIRS beamline was simulated with a Monte Carlo (MC) 
code, according to design information about elements 
position, size and composition. Validation went through 
comparison between simulated and measured pristine and 
Spread Out Bragg Peaks, ridge filter based, in water. CT 
scan, structure set, plan and dose files of 10 treatment fields 
delivered at NIRS were exported in DICOM format, for 
prostate (3.6 Gy (RBE)NIRS per 16 fractions), Head & Neck (4 
Gy (RBE)NIRS per 16 fractions) and pancreas (4.6 Gy (RBE)NIRS 
per 12 fractions) patients. Patient specific passive system 
geometries (range shifter, MLC, compensator, collimator) 
were implemented, for each field, to simulate delivered Dabs 
distributions. The MC code was then interfaced with LEM to 
calculate DRBE resulting from the application of a different 
RBE model to NIRS physical dose. MC and TPS calculated Dabs 
and DRBE were compared in terms of dose profiles and target 
median dose. Patient CT and structure sets were also 
imported in a LEM-based commercial TPS where plans were 
optimized prescribing the non-converted and converted DRBE 
values, respectively. 
The agreement between MC and measured depth dose 
profiles in water, in terms of particle range, peak to plateau 
ratio and spread out profile shape, demonstrated beamline 
model accuracy. Patient dose distributions were correctly 
reproduced by MC in the target region, with an overall target 
median dose difference < 2%. MC median DRBE resulted 16% 
higher than NIRS reference, for the lower prostate dose 
level, 10% for head and neck and 4.5% for pancreas, in 
agreement with respective LEM-based prescription doses, 
adopted in our protocols. Deviations are expected to be close 
to zero around a prescription DRBE = 5 Gy (RBE). Aside from 
unavoidable differences in dose profile shape, severe target 
under-dosage was shown in LEM-based optimized plans, when 
uncorrected DRBE were prescribed.  
The delivery of a voxel by voxel iso-effective plan, if 
different RBE models are employed, is not feasible; it is 
however possible to minimize differences in dose deposited 
in the target. Dose prescription is a clinical task which 
ultimately depends only on the radiation oncologist clinical 
decision; in this study we made an attempt to avoid 
systematic errors which could potentially compromise tumor 
control.  
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Purpose: The aim of this study is to compare the radiation 
induced DNA damage done by internal Auger-electron 
cascades with external exposures of sparsely ionizing 
radiation such as γ-rays.  
Background: Auger emitters decay by internal conversion (IC) 
or electron capture (EC) producing a number of Auger 
cascade electrons. These electrons are so low in energy that 
their range in tissue is in the order of nm-μm. This means 
that if the decay happens nearby the DNA, the Auger cascade 
electrons can produce a cluster of complex DNA damage. 
These clusters of DNA damage are much harder to repair and 
are therefore believed to be much more harmful to the cell 
than dispersed DNA damage, which are primarily produced by 
low LET radiation. Due to their short tissue range and the 
severe DNA damage produced, Auger emitters may be able to 
kill only the target cell while sparing non-targeted cells. This 
makes them a potential tool for radionuclide 
therapy(1,2,3,4). 
Material/Methods: In order to compare the radiation effects 
by the Auger emitter to that of external γ-rays we need to be 
able to estimate the dose delivered. As Auger cascade 
electrons have a very short range the precise spatial 
distribution of the decays is of high importance. 
We are currently working with two Auger emitters, Cs-131 
and La-135. First experiments have been performed using 
HeLa cells, which were incubated with either Cs-131 or La-
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135 for internal exposure. Theses ions seem to be taken up 
by the cells. However more knowledge about the bio-kinetics 
of these auger emitters is needed to estimate the dose rates 
and the dose distribution in the cell. As the cells take up the 
Auger emitter, the dose rate by the internal Auger decays are 
continuously changing as a function of cellular accumulation 
and half-life of the isotope. 
Uptake curves are therefore produced by incubating HeLa 
cells with Auger-electron emitters for various amounts of 
time and with different levels of radioactivity to calculate 
the changing dose rate and accumulated dose.  These 
conditions will be mimicked as closely as possible with 
external γ-rays, by moving the cells closer to the source (Cs-
137). DNA damage will be assessed by flow cytometry 
measurements (MUSE) of phosphorylated histone H2AX (γ-
H2AX) and/or the clonogenic cell survival assay.  
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Purpose: The importance of MRI steadily increases in 
radiation oncology not only as multimodality imaging device 
but also as an implemented online imaging technology. 
Imaging using MRI shows advantages compared to CT or CBCT 
offering superior soft tissue contrast without additional dose. 
Also in particle beam therapy integrated MR guided 
treatment units have great potential. A complete 
understanding of the particle beam characteristics in the 
presence of magnetic fields is required. So far, studies in this 
area are limited. 
Material and Methods: Protons (60-250MeV) and carbon ions 
(120-400MeV/u) in the clinically required energy range 
impinging on a phantom of 35x35x50cm³ size were simulated 
using the MC framework GATE 7. Homogeneous magnetic 
fields of 0.35T, 1T and 3T perpendicular to the initial beam 
axis were applied. The beam deflection, shape, and the 
energy spectrum at the Bragg peak area was analyzed. A 
numerical algorithm was developed for deflection curve 
generation solving the relativistic equations of motion taking 
into account the Lorentz force and particle energy loss. 
Additionally, dose variations on material boundaries induced 
by magnetic fields were investigated for 250MeV protons. 
Results: Transverse deflections up to 99mm were observed 
for 250MeV protons at 3T. Deflections for lower field 
strengths (e.g. future hybrid open-MRI proton delivery 
systems) yielded 12mm for 0.35T and 34mm for 1T. A change 
in the dose distribution at the Bragg-peak region was 
observed for protons. Energy spectrum analysis showed an 
asymmetric lateral energy distribution. The different particle 
ranges resulted in a tilted dose distribution, see Fig.1.The 
numerical algorithm successfully modeled the deflection 
curve, with a maximum deviation of 1.8% and calculation 
times of less than 5ms. For a 250MeV proton beam passing in 
a 3T field through multiple slabs (water-air-water), only a 4% 
local dose increase at the first boundary was observed in 
single voxels due to the electron return effect, more than a 
factor 10 lower compared to a photon beam [1]. 
 
 
 
Fig1: Deformed 2D dose distribution at the Bragg peak area 
for a 250MeV proton beam in a 3T field 
 
Conclusion: Beam deflections in magnetic fields could be 
described by a numerical algorithm. The observed change in 
dose distribution in the Bragg-peak region has to be taken 
into account in future dose calculations. However, local dose 
changes due to boundary effects seem to be negligible for 
clinical applications. Current work in progress deals with the 
inclusion of magnetic field effects in a dose calculation 
algorithm for particles. 
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The mechanism of tumor cure by ionizing radiation is 
regarded tumor cell autonomous, effected by misrepair of 
radiation-induced DNA double strand breaks (DSBs), to a large 
extent via the function of error prone non-homologous end 
joining (NHEJ). This model prevails at the low dose range, 
with cure depending on tumor phenotypic propensity for 
NHEJ misrepair, and requires repeated exposures for tumor 
ablation.  Here we report high (>10Gy) single dose 
radiotherapy (SDRT) employs an alternative dual target 
model, inducing in addition to DSBs also an early wave of 
acid sphingomyelinase (ASMase)-mediated microcirculatory 
ischemia/reperfusion (I/R) injury. Reactive oxygen species 
(ROS) induced therein in parenchymal tumor cells disrupt 
activation of homology-directed repair (HDR), leading to 
catastrophic reprograming of DSB repair. We show Ku- and 
53BP1-mediated NHEJ are not affected, although 
MDC1/53BP1 resolution is delayed, while engagement of the 
HDR mediator cluster in DSB repair is aborted, promoting a 
divergent DSB repair pathway, generation of massive 
chromosomal alteration and reproductive tumor clonogen 
demise. Scavenging of ROS with the SOD-mimetic tempol 
reversed the loss-of-function HDR and tumor cell lethality, 
aborting tumor cure by SDRT. We define I/R-mediated loss-
of-function HDR as the detrimental SDRT damage response, 
